Congo Ebola Outbreak Climbs to 550 Confirmed Cases. Recoveries and New Treatment Infrastructure Signal Slow Progress.

Since the outbreak was declared on May 15, the confirmed case count in the Democratic Republic of Congo has climbed from roughly 134 cases at the end of May to 550 as of June 8, according to WHO's Health Emergency Alert and Response Operations Director Dr. Abdirahman Mahamud, speaking to reporters in Geneva on June 9. The death toll in DRC stands at 101 confirmed deaths. Uganda has separately reported 19 confirmed cases and 2 deaths, with no evidence of community transmission there as of the same date, per UN News.

Dr. Mahamud was direct about why the case count jumped: more labs. "The rise in confirmed cases is due to the scale-up of testing," he said. A new fully functional lab opened in Mongbwalu, and more decentralized facilities have cut turnaround times. In Bunia, the capital of Ituri province and the epicentre accounting for 94 percent of DRC's cases, results come back in one to two hours. In remote areas, that can stretch to 24 hours. Sample transport alone can take eight hours.

Recoveries Are Real, But Hard-Won

The human side of this outbreak has a counterweight to the death toll. Daniel Kitambala, a 49-year-old from Ituri province, walked out of a treatment centre after two negative Ebola tests, roughly three weeks after admission. BBC News witnessed health workers in green scrubs singing and dancing as they escorted him out. "That disease is terrible. I was feeling very ill when I came here. But God is great, I am well now," Kitambala told the BBC.

By June 1, five patients had recovered in total, including four nurses and a laboratory worker, according to WHO updates reported by UN News. The WHO's own Director-General, Dr. Tedros Adhanom Ghebreyesus, announced the first four discharges on May 31 during the opening of a new Ebola Treatment Centre in Bunia. That facility has 24 beds, with total capacity expandable to 60, and WHO is building an annex with up to 42 additional beds, per UN News.

Nurse Ezo Étienne, one of the recovered patients, described his treatment to the Associated Press as purely symptomatic: anti-nausea medications, fluids, and pain relievers. "That was all they could provide," he told AP. He urged healthcare workers not to dismiss early symptoms, vomiting and headaches, warning that misinformation causes people to delay seeking care.

No Vaccine, No Treatment. Trials in the Pipeline

The core problem has not changed. Bundibugyo is a rare Ebola species and there is NO licensed vaccine or approved treatment for it, unlike the more common Zaire strain. WHO advisory groups have identified three candidate therapeutics for clinical trials: the monoclonal antibodies MBP 134 and maftivimab, plus a third compound. WHO's role is coordinating trial access with DRC and Ugandan health authorities. When those trials begin and what timeline they're on has not been publicly confirmed in any of these sources as of June 16.

The Case for Concern About the Response

Critics of the international health response have a legitimate point. This outbreak has now passed 550 confirmed cases with no vaccine, contact tracing reaching only 62 percent of identified contacts, and a geography the size of France with limited connectivity. More than 1.2 million people in Ituri province alone require humanitarian assistance because of decades of conflict, per UN News. Treatment centres and lab infrastructure are improving, but the window to contain the outbreak before it spreads beyond manageable boundaries is finite. WHO's own target for contact tracing coverage is 90 to 95 percent. The current 62 percent leaves a wide margin for undetected transmission chains.

The WHO and DRC health authorities counter that the current system is functioning as designed: surveillance feeding into contact tracing feeding into treatment centres, with efficient data sharing. Dr. Mahamud described "slow and steady progress" built on community trust. Health workers who are local to the region are identified as essential to that trust-building in the WHO's framing, and the recovery figures show the system can work when patients reach care early.

What Actually Needs to Happen

5,040 contacts had been identified and placed under follow-up across Ituri, North Kivu, and South Kivu provinces as of June 6, per UN News. Getting contact tracing from 62 percent to the 90-to-95 percent target is the single most actionable metric WHO has named. Dr. Mahamud said reaching that threshold was expected "in the coming weeks" but did not commit to a specific date. Sixteen health workers have already contracted the virus themselves, a figure that indicates the occupational risk remains high.

The unresolved question as of June 16 is whether the clinical trials for MBP 134, maftivimab, and the third candidate therapeutic can be initiated fast enough to provide evidence-based treatment options before the outbreak either expands further or burns out on its own.